Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Cca08g01635 ATGAACGAAGCAACAATGAGGATTTCAACACATGCAATTGTGCTCCTTTTGATATTTTCTTGTGCACTTCTATGCCATGGCAATGAAAGTACTATGAGAGTGCTTTTGGAGGTGAAATCTTCGTTCACTGAAGACCCAGAAAATGTTTTAAGGGATTGGTCAGAGAACAACACAGATTACTGTAGTTGGAGAGGAGTGTCATGTGGTTCAAAGAAGATGTTAGAGTTGGAGTTAGAATCCAAACCTTTGGATAATGATGACTCGGTGCAAGTAGTGGTGGGACTCAACCTGTCCGAGTCATCACTCAGTGGGTCAATATCACCATCACTCGGTCGTTTGCAAAACCTGCTCCACCTTGATCTCTCTAATAACCGACTCGAGGGTCCCATTCCACCTACCCTCTCCAACCTCTCTTCATTGGAATCTCTCTTTCTCTACTCCAACCAACTCACAGGCCCTATCCCCACCGAGTTCGACTCGCTTCTGAATCTCCGAGTTTTGCGAATCGGTGACAATGGACTCACTGGCACGATTCCCGCGTCACTGGGGAATCTGGTCAACCTTGTGAGCCTTGGCTTAGCCTCATGCAGACTCAATGGGTCAATTCCACCCCAACTCGGTCGACTCAGTGAGTTGGAATATCTGATCCTGCAGGATAACGAGTTGACTGGTCGGATTCCGTCTGAATTGGGGAACTGCTCGAGCCTTATAGTCTTCGCTGTTGCTGGCAACAGACTCAACGACTCAATCCCGAGTGAGCTGAGTCAACTCGGAAAACTTCAAACTCTGAACCTTGCCAACAACAGCTTATCCGGGTCGATTCCGAGTCAACTTGGTGCGCTGAGTCAGCTTAGATATCTTAATTTCGTGGGGAACCGGCTCGAGGGTAGTATTCCACCGTCTTTGGCTCAATTGGTTAACCTTCAAAATCTTGACTTGTCAAAGAATATACTGAGTGGGGAAATTCCAAAGGAGTTAGGGAACATGGGTGAGTTACAATTCTTGGTTCTCTCTGAGAACAAACTACATGGGACCATTCCAAGAACCATATGTTCCAATGCAACAAATTTGTTGAGCTTGATGATAGCAGAGAGTGGACTTCATGGTGAGATACCAGCTGAGTTGGGTCAGTGCCAATCACTGAAGCAACTTGATTTGTCAAACAATTCTCTCAGTGGGTCAATACCTAATGAGGTTTATGGGTTGGTGGGGCTAATTAGTCTCTTGCTTCACAATAACACCTTGGTTGGTTCAATCTCTCCTTTCATAGGGAACCTCACTAACATGCAGACTCTTGCATTGTTTCACAACAGGTTGCAGGGTGGTCTTCCCAGAGAGATTGGGAGGCTGGGGAAATTGGAGATACTGTTTCTTTACGATAATATGTTGTCAGGGAAGATTCCTTTGGAGATTGGAAACTGCTCAAGCTTGCAAATGGTTGATTTCTATGGAAACTATTTCAGTGGGGAAATTCCCTTCACCATTGGGAGGCTGAAAGATTTGAACTTTTTGCACCTCAGGCAGAATGAGCTTGAGGGTGTCATTCCCCCCACACTTGGGAACTGTCATAAAATGAGTGTGTTGGATTTGGCAGATAATCAGCTTTCAGGTGGCATTCCTGCAACATTTGGATTCCTCAGAGAGTTGACGCAGTTCATGCTCTACAACAATCATCTTGAAGGTAGTCTTCCTCACCAACTTGTAAATGTAGCAAACTTGACCAGAGTGAATCTTTCAAACAACAGACTCAATGGTAGTTTGGTTGCATTGTGTCGCTCGATGTCTTTTCTTTCTTTTGATGTCACAGATAACCAATTTGATGGTGAAATACCCTTTCTCCTGGGAAACTCGCCTTTCCTTGAGAGGCTGAGATTAGGTAACAACAAATTTTCTGGCGAAATTCCAAGGACATTGGGAAAACTCACTATGTTGTCATTGTTAGACGTCTCAGGAAATTCACTCACTGGACCAATACCCGATGAGCTTTCCTTGTGTAATAATCTGACTCACATTGATTTAAACAACAACCTTCTATCTGGAAGCATACCATCATGGATTGGAAGTTTGCCAGAGTTGGGAGAGCTTAGGCTCTCATTCAATCAATTTCATGGGTCTATTCCACCAGGCCTATTCAAACAACAAAAGTTGATTGATCTTTCCTTGGATAACAATTCTCTTAGTGGAAGTCTCCCTGATGATATTGGAGGCCTTGCATCCCTTAATGTACTCAGACTTGACCATAATTTCTTGTCTGGACCAATCCCTCATACAATTGGTAAATTGAGCAATCTTTATAAGCTGCAGCTATCAAGGAATCACTTTAGTGGTGAGATACCAATTGAGATAGGAAATATGCAAAATCTCCAAAGCATTTTGGACCTCAGTTACAATAATCTCTCTGGTCATATCCCATCTTCACTTGGCATGCTGTCAAAATTGGAAGTACTTGACCTTTCTCACAATCAACTCAGTGGAGAAGTGCCTTCGATAATTGGTGAAATTTGGAGCTTGGAGAAGCTTGACATCTCTTACAATAACCTTCAAGGTGCATTGGATAAGCAATTCTACCGCTGGCCACATGAGGCGTTTGAAGGGAACCTTTATCTTTGTGGAGCCTCTCTTGGAAGCTGCAACTGCAACCGTGGTGAAGCTTCCTGCAATAAGCCATTAAGCAACACAACAGTGATTATAGTCTCTGCACTTTCAACTTTAGCTGCTATTGCTCTTCTTGTACTTTTTGTGATCATCTTCTTGAAAAACAAGCAAGAAATTTTCAGGAGAGGCAGTGAAGTGAGTTTTATTTTCTCCTCTTCATCGCGAGCACAAAGACGAACCTTGGTCCCTCTAAGTACTGCTCCTGGAAAGCGAGATTTCAGGTGGGAAGATATCATGAGTGCCACAAACAACTTAAGTGATGAGTTCATAATTGGTTATGGAGGTTCTGGGACAGTCTACAGAGTTGAATTGCCCACTGGAGAGACTGTGGCTGTCAAGAAGATTTCCTTGAAAGATGAATATCTGTTGAACAAAAGCTTTATAAGAGAAATCAAGACTCTGGGGAGGATCAAGCATAGACATCTGGTGAAACTGGTAGGCTGTTGTAGCAATAGAAACAAAGGAACAGGTTGGAATCTGttgatatatgagtatatggagaatggaagtgtatgggattggcttcatggggaacccctcaaatcaaaggggagacttgattgggacacaaggttcaaaattgctgtgggattagctcatggagtggagtacctccatcatgattgtgtgccaaagatcattcacagggacatcaaatccagcaacatattgctagattccaacatggaggcacacttgggagactttggactggccaaatCACTCATTGAGAATCATGAATCCAATACTGAGTCTAATTCTTGTTTTGCTGGCTCTTACGGTTACATAGCCCCAGAGTTTGCATACTCACTGAGGGCCACAGAGAAAAGTGATGTGTACAGCATGGGAATTGTGCTTATGGAACTTGTTAGTGGTAAAATGCCAACAGATGCAGATTTCAGAGGAGAGATGGATATGGTGAGATGGGTGGAGGTGCATGTGGACATGCATGGCACTTCATGCGATGAAGTGATGGATCCTCAGCTGAAACCCCTTTTGCCTGGTGAAGAGTTTGCTGCTTTGCAGGTGCTTGAGATAGCCATACAGTGCACAAAAACTGCACCACAGGAGAGGCCAACCTCACGCCAAGTATGCGATCTTCTTCAGCGTGTGTCCAACAACAAAAAGGTGGAGTTTGAGAAGAAGAATTTGGATGATTACTAG 3819 0.4093 MNEATMRISTHAIVLLLIFSCALLCHGNESTMRVLLEVKSSFTEDPENVLRDWSENNTDYCSWRGVSCGSKKMLELELESKPLDNDDSVQVVVGLNLSESSLSGSISPSLGRLQNLLHLDLSNNRLEGPIPPTLSNLSSLESLFLYSNQLTGPIPTEFDSLLNLRVLRIGDNGLTGTIPASLGNLVNLVSLGLASCRLNGSIPPQLGRLSELEYLILQDNELTGRIPSELGNCSSLIVFAVAGNRLNDSIPSELSQLGKLQTLNLANNSLSGSIPSQLGALSQLRYLNFVGNRLEGSIPPSLAQLVNLQNLDLSKNILSGEIPKELGNMGELQFLVLSENKLHGTIPRTICSNATNLLSLMIAESGLHGEIPAELGQCQSLKQLDLSNNSLSGSIPNEVYGLVGLISLLLHNNTLVGSISPFIGNLTNMQTLALFHNRLQGGLPREIGRLGKLEILFLYDNMLSGKIPLEIGNCSSLQMVDFYGNYFSGEIPFTIGRLKDLNFLHLRQNELEGVIPPTLGNCHKMSVLDLADNQLSGGIPATFGFLRELTQFMLYNNHLEGSLPHQLVNVANLTRVNLSNNRLNGSLVALCRSMSFLSFDVTDNQFDGEIPFLLGNSPFLERLRLGNNKFSGEIPRTLGKLTMLSLLDVSGNSLTGPIPDELSLCNNLTHIDLNNNLLSGSIPSWIGSLPELGELRLSFNQFHGSIPPGLFKQQKLIDLSLDNNSLSGSLPDDIGGLASLNVLRLDHNFLSGPIPHTIGKLSNLYKLQLSRNHFSGEIPIEIGNMQNLQSILDLSYNNLSGHIPSSLGMLSKLEVLDLSHNQLSGEVPSIIGEIWSLEKLDISYNNLQGALDKQFYRWPHEAFEGNLYLCGASLGSCNCNRGEASCNKPLSNTTVIIVSALSTLAAIALLVLFVIIFLKNKQEIFRRGSEVSFIFSSSSRAQRRTLVPLSTAPGKRDFRWEDIMSATNNLSDEFIIGYGGSGTVYRVELPTGETVAVKKISLKDEYLLNKSFIREIKTLGRIKHRHLVKLVGCCSNRNKGTGWNLLIYEYMENGSVWDWLHGEPLKSKGRLDWDTRFKIAVGLAHGVEYLHHDCVPKIIHRDIKSSNILLDSNMEAHLGDFGLAKSLIENHESNTESNSCFAGSYGYIAPEFAYSLRATEKSDVYSMGIVLMELVSGKMPTDADFRGEMDMVRWVEVHVDMHGTSCDEVMDPQLKPLLPGEEFAALQVLEIAIQCTKTAPQERPTSRQVCDLLQRVSNNKKVEFEKKNLDDY 1272
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 402 490 IPR032675 -
Cca08g01635 1272 Pfam Protein kinase domain 975 1250 IPR000719 GO:0004672|GO:0005524|GO:0006468
Cca08g01635 1272 ProSiteProfiles Prokaryotic membrane lipoprotein lipid attachment site profile. 1 21 - -
Cca08g01635 1272 ProSiteProfiles Leucine-rich repeat profile. 812 834 IPR001611 GO:0005515
Cca08g01635 1272 Pfam Leucine Rich Repeat 380 399 IPR001611 GO:0005515
Cca08g01635 1272 Pfam Leucine Rich Repeat 115 137 IPR001611 GO:0005515
Cca08g01635 1272 SMART serkin_6 970 1256 IPR000719 GO:0004672|GO:0005524|GO:0006468
Cca08g01635 1272 SUPERFAMILY L domain-like 351 657 - -
Cca08g01635 1272 Pfam Leucine rich repeat 762 823 IPR001611 GO:0005515
Cca08g01635 1272 Pfam Leucine rich repeat 690 748 IPR001611 GO:0005515
Cca08g01635 1272 PRINTS Leucine-rich repeat signature 381 394 - -
Cca08g01635 1272 PRINTS Leucine-rich repeat signature 810 823 - -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 757 879 IPR032675 -
Cca08g01635 1272 ProSitePatterns Protein kinases ATP-binding region signature. 976 999 IPR017441 GO:0005524
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 491 592 IPR032675 -
Cca08g01635 1272 ProSiteProfiles Protein kinase domain profile. 970 1256 IPR000719 GO:0004672|GO:0005524|GO:0006468
Cca08g01635 1272 Gene3D Transferase(Phosphotransferase) domain 1 1051 1271 - -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 240 401 IPR032675 -
Cca08g01635 1272 PANTHER LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE GSO1 8 1268 - -
Cca08g01635 1272 SUPERFAMILY L domain-like 596 872 - -
Cca08g01635 1272 ProSitePatterns Serine/Threonine protein kinases active-site signature. 1098 1110 IPR008271 GO:0004672|GO:0006468
Cca08g01635 1272 PANTHER LEUCINE-RICH REPEAT RECEPTOR PROTEIN KINASE EMS1 8 1268 - -
Cca08g01635 1272 SUPERFAMILY L domain-like 48 368 - -
Cca08g01635 1272 Gene3D Phosphorylase Kinase; domain 1 930 1050 - -
Cca08g01635 1272 Pfam Leucine rich repeat N-terminal domain 34 68 IPR013210 -
Cca08g01635 1272 SMART LRR_typ_2 137 160 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 113 136 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 161 185 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 426 450 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 570 593 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 329 353 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 209 233 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 689 713 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 257 281 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 810 834 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 761 785 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 641 665 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 498 522 IPR003591 -
Cca08g01635 1272 SMART LRR_typ_2 378 402 IPR003591 -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 662 756 IPR032675 -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 162 239 IPR032675 -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 30 161 IPR032675 -
Cca08g01635 1272 Gene3D Ribonuclease Inhibitor 593 661 IPR032675 -
Cca08g01635 1272 SUPERFAMILY Protein kinase-like (PK-like) 948 1253 IPR011009 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Cca08g01635 Cca-Chr8 47792110 47796561 Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Cca08g01635 638 857 Receptor kinase-like Gene Family AT5G56040 30.859 8.58e-16 81.3
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Cca08g01635 Pkinase 1.8e-45 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Cca08g01635 - - gmx:100797153 1981.07